News & Events

Philogen to attend the Antibody Engineering & Therapeutics on December 4-8, 2022 in San Diego

Dec 3, 2022

Philogen announces its attendance at the Antibody Engineering & Therapeutics 2022.
Prof. Dario Neri, CEO and CSO of Philogen, is giving a lecture entitled “Small Molecule-drug Conjugates (SMDCs) and Antibody-drug Conjugates (ADCs): A Comparative Evaluation
Please follow the link below for more information